Form4insider filings, from the source

SEC Form 4 · accession 0001140361-16-046270

Alaunos Therapeutics, Inc. · TCRT

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Randal J Kirk
Director · 10% Owner
Period of report
Dec 31, 2015
Accepted (ET)
Jan 4, 2016 · 4:30 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001107421

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Dec 31, 2015A26,661$0.00A122,309D
Common StockF2holding———3,479,685Iby R.J. Kirk DOT
Common StockF2holding———23,349Iby JPK 2008
Common StockF2holding———23,504Iby MGK 2008
Common StockF2holding———40,954Iby ZSK 2008
Common StockF2holding———240Iby Lotus
Common StockF2holding———53,245Iby Staff 2001
Common StockF2holding———9,537Iby Sr. Staff
Common StockF2holding———337,333Iby JPK 2009
Common StockF2holding———358,386Iby MGK 2009
Common StockF2holding———34,318Iby ZSK 2009
Common StockF2holding———29,066Iby ADC 2010
Common StockF2holding———154,181Iby MGK 2011
Common StockF2holding———138,975Iby JPK 2012
Common StockF2holding———61,262Iby Kellie L. Banks LTT
Common StockF3holding———2,359,608Iby Kapital Joe
Common StockF3holding———889,513Iby Mascara Kaboom
Common StockF3holding———395,791Iby Senior Staff 2008
Common StockF3holding———222,680Iby Staff 2010
Common StockF3holding———111,339Iby Incentive 2010
Common StockF3holding———352,477Iby Senior Staff 2007
Common StockF3holding———176,238Iby Staff 2007
Common StockF3holding———58,746Iby Incentive 2007
Common StockF3holding———173,111Iby Staff 2009
Common StockF3holding———86,556Iby Incentive 2009

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses